1. Catalog
  2. 2026 SSC Adult Guidelines Updates: What Clinicians ...
2026 SSC Adult Guidelines Updates: What Clinicians Need to Know
Product Information

Release date: April 7, 2026

SCCM Product Code: SSCA26

Privacy Statement

View the Society of Critical Care Medicine Privacy Statement  

SCCM copyrights the contents of all material available on this site unless otherwise indicated. You may not modify, reproduce or distribute the content on this site, the design or layout of the site, or the SCCM logo without written permission. 

Disclaimer Regarding Third-Party Content
This site and/or course may contain active/live links, materials, or information provided by third parties. The active/live links, materials, or information are those of the respective third party and not of the Society or its affiliates. The Society makes no representation with respect to such third-party links, materials, or information, nor does the Society guarantee or endorse the quality, non-infringement, accuracy, completeness, timeliness, or reliability of such third-party links, materials, or information. Use of the links, materials, or information from said third party is voluntary, and your reliance on it should be undertaken only after an independent review of its accuracy, completeness, efficacy, and timeliness.
Software/Hardware and Internet Requirements
Review the software/hardware and internet requirements here
Learning Objectives

At the conclusion of this webcast, participants will be able to:

  • Review the purpose, scope, and clinical impact of the Adult Surviving Sepsis Campaign (SSC) guidelines as a foundation for evidence-based sepsis care.
  • Examine newly introduced and revised recommendations within the updated Adult SSC guidelines, with attention to changes that influence clinical decision-making.
  • Discuss the practical application of Adult SSC recommendations in clinical practice, supporting timely identification and management of sepsis and septic shock in adults.
Target Audience
This activity is intended to meet the needs of all practitioners who care for critically ill patients.  
SCCM Grievance Procedures Policy

To provide due process in the evaluation and mediation of grievances concerning ACE activities, this Grievance Procedures Policy was developed. Grievances may concern, but are not limited to, the awarding of credit for individual participation and/or registration fees issues.  

  • A written complaint or grievance should be submitted to the Education Department. 

  • The Education Department will attempt to resolve the grievance of the complainant. 

  • If the initial response is unsatisfactory to the complainant, the matter will be referred to the Chief Executive Officer (CEO)/Executive Vice President (EVP) for action. 

  • If the response from the CEO/EVP is unsatisfactory to the complainant, the matter will be referred to the SCCM Executive Committee. The ruling of the Executive Committee will be final. 

Disclosures
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been mitigated through an established conflict-of-interest resolution process and have stated that these reported relationships will not have any impact on their ability to provide unbiased content.

Planners:  
 

Cherylee W.J. Chang MD, FCCM, FACP, FNCS

Duke University School of Medicine

Durham, North Carolia, USA  

President, Society of Critical Care Medicine 
No relevant financial relationship(s) to disclose 

Vishakha Kumar MD, MBA

Society of Critical Care Medicine

Mount Prospect, Illinois, USA

No relevant financial relationship(s) to disclose


Jan J. De Waele MD, Ph.D. MD, MBA

Ghent University Hospital

Ghent, Belgium 

Consulted for Biomerieux, Grifols, Menarini, MSD, Pfizer, Roche Diagnostics, and Viatris (fees and honoraria paid to institution) 
Supported by a Sr Clinical Research Grant from the Research Foundation Flanders (FWO, Ref.  1881020N)

 


Faculty:  

Hallie C. Prescott MD, MSc, FCCM 

VA Ann Arbor Healthcare System 

Ann Arbor, Michigan, USA
Consultant for Aurobac Therapeutics

Massimo Antonelli MD

Universita' Cattolica del Sacro Cuore
Roma, Italy
Advisor for AstraZeneca and Grifols 
Advisor for Menarini and Shionogi
Consultant for Baxter

Jan J. De Waele MD, Ph.D. MD, MBA

Ghent University Hospital

Ghent, Belgium 

Consulted for Biomerieux, Grifols, Menarini, MSD, Pfizer, Roche Diagnostics, and Viatris (fees and honoraria paid to institution) 
Supported by a Sr Clinical Research Grant from the Research Foundation Flanders (FWO, Ref.  1881020N)

 

 

Summary
Availability:
Registration Required
Location:
Online Meeting
Date / Time:
Apr 07, 2026 10:00 AM - 10:45 AM CT
Credit Offered:
No Credit Offered